According to IMARC Group’s latest report, titled “Remote Patient Monitoring Market Size: Industry Trends, Share, Growth, Opportunity and Forecast 2021-2026,” the global remote patient monitoring market reached a value of US$ 964 Million in 2020. Looking forward, the market is expected to exhibit strong growth during 2021-2026.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Remote patient monitoring (RPM) is an ambulatory healthcare system that uses digital technology to acquire medical and other health data about patients outside healthcare establishments. This information is then sent to healthcare professionals with the help of telehealth software applications installed on computers, smartphones or other hand-held devices to monitor the condition and improve the quality of care given to patients.
Request Free Sample Report: https://www.imarcgroup.com/remote-patient-monitorning-market/requestsample
Market Trends:
The market is primarily driven by the sudden outburst of the highly contagious coronavirus disease (COVID-19). Healthcare providers worldwide are using RPM systems to track patients with moderate COVID-19 symptoms and offer prompt hospital-based care. This helps to free up hospital resources for treating more critical patients. Besides this, the rising incidences of cardiovascular diseases, along with the increasing geriatric population, which is more susceptible to chronic conditions, is also boosting the demand for RPM. Furthermore, the introduction of innovative devices, improving healthcare infrastructure and rapid technological advancements are expected to create a significant impact on the market growth in the coming years.
Ask Analyst and Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/remote-patient-monitorning-market
List of Key Companies Covered in this Market Report:
- Abbott Laboratories (NYSE: ABT)
- AMD Global Telemedicine Inc.
- BIOTRONIK SE & Co. KG
- Boston Scientific Corporation (NYSE: BSX)
- Dexcom, Inc. (NASDAQ: DXCM)
- GE Healthcare Inc. (Danaher Corporation) (NYSE: GE)
- Honeywell International Inc. (NYSE: HON)
- Koninklijke Philips N.V. (AMS: PHIA)
- Medtronic Inc. (NYSE: MDT)
- Nihon Kohden Corporation (TYO: 6849)
- OSI Systems Inc. (NASDAQ: OSIS)
- Roche Holding AG (SWX: RO)
The report has segmented the market on the basis of device type, application, end-use and geography.
Breakup by Device Type:
- Blood Pressure Monitor
- Glucose Monitor
- Heart Rate Monitor
- Pulse Oximeters
- Respiratory Monitor
- Others
Breakup by Application:
- Cancer Treatment
- Cardiovascular Diseases Treatment and Monitoring
- Diabetes Treatment
- Sleep Disorder Treatment
- Weight Management and Fitness Monitoring
- Others
Breakup by End-Use:
- Hospitals and Clinics
- Homecare Settings
- Others
Breakup by Geography:
- North America (U.S. & Canada)
- Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
- Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
- Latin America (Brazil, Mexico)
- Middle East & Africa
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021- 2026)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800 Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
I do not even understand how I ended up here but I assumed this publish used to be great
There is definately a lot to find out about this subject. I like all the points you made
Some really excellent info I look forward to the continuation.
Nice post. I learn something new and challenging on blogs I stumbleupon on a daily basis.
Good post! We will be linking to this particularly great post on our site. Keep up the great writing
Hi there to all for the reason that I am genuinely keen of reading this website’s post to be updated on a regular basis. It carries pleasant stuff.
Very nice blog post. I definitely love this site. Stick with it!
Greetings! Very helpful advice in this particular article! It is the little changes which will make the most important changes. Thanks a lot for sharing!
Very nice blog post. I definitely love this site. Stick with it! .